Non-dipping pattern in early-stage diabetes: association with glycemic profile and hemodynamic parameters.


Journal

Journal of human hypertension
ISSN: 1476-5527
Titre abrégé: J Hum Hypertens
Pays: England
ID NLM: 8811625

Informations de publication

Date de publication:
09 2022
Historique:
received: 27 03 2021
accepted: 26 07 2021
revised: 21 07 2021
pubmed: 18 8 2021
medline: 15 9 2022
entrez: 17 8 2021
Statut: ppublish

Résumé

Patients with longstanding diabetes exhibit diminished nocturnal blood pressure (BP) drop, yet this phenomenon remains understudied in the early stages of the disease. Eighty patients with newly diagnosed (<6 months) Diabetes Mellitus type 2 (T2DM) and 80 non-T2DM individuals underwent office and 24-h ambulatory BP measurements, estimation of hemodynamic parameters using impedance cardiography and blood tests. Ten-year atherosclerotic cardiovascular disease (ASCVD) risk score was calculated. T2DM patients exhibited higher nighttime systolic blood pressure (SBP) (p = 0.028) and lower dipping (p < 0.001) compared to controls. In the total population, dipping correlated negatively with age, HbA

Identifiants

pubmed: 34400769
doi: 10.1038/s41371-021-00587-4
pii: 10.1038/s41371-021-00587-4
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

805-810

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Nikolaidou B, Gkaliagkousi E, Anyfanti P, Gavriilaki E, Lazaridis A, Triantafyllou A, et al. The impact of hyperglycemia on urinary albumin excretion in recent onset diabetes mellitus type II. BMC Nephrol. 2020;21:119.
doi: 10.1186/s12882-020-01774-0 pubmed: 32252655
Kosiborod M, Gomes MB, Nicolucci A, Pocock S, Rathmann W, Shestakova MV, et al. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovasc Diabetol. 2018;17:150.
doi: 10.1186/s12933-018-0787-8 pubmed: 30486889
American Diabetes A.11. Microvascular complications and foot care: standards of medical care in diabetes-2020. Diabetes Care. 2020;43 Suppl 1:S135–S51.
doi: 10.2337/dc20-S011
Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet. 2012;380:601–10.
doi: 10.1016/S0140-6736(12)60987-8 pubmed: 22883509
Nilsson PM, Cederholm J, Zethelius BR, Eliasson BR, Eeg-Olofsson K, Gudbj Rnsdottir S. Trends in blood pressure control in patients with type 2 diabetes: data from the Swedish National Diabetes Register (NDR). Blood Press. 2011;20:348–54.
doi: 10.3109/08037051.2011.587288 pubmed: 21675827
Cuspidi C, Sala C, Tadic M, Gherbesi E, De Giorgi A, Grassi G, et al. Clinical and prognostic significance of a reverse dipping pattern on ambulatory monitoring: an updated review. J Clin Hypertens. 2017;19:713–21.
doi: 10.1111/jch.13023
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104. 2018
doi: 10.1093/eurheartj/ehy339 pubmed: 30165516
Kario K. Nocturnal hypertension: new technology and evidence. Hypertension. 2018;71:997–1009.
doi: 10.1161/HYPERTENSIONAHA.118.10971 pubmed: 29712746
Fogari R, Zoppi A, Malamani GD, Lazzari P, Destro M, Corradi L. Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetes. Prevalence of impaired diurnal blood pressure patterns. Am J Hypertens. 1993;6:1–7.
doi: 10.1093/ajh/6.1.1 pubmed: 8427656
Dost A, Klinkert C, Kapellen T, Lemmer A, Naeke A, Grabert M, et al. Arterial hypertension determined by ambulatory blood pressure profiles: contribution to microalbuminuria risk in a multicenter investigation in 2,105 children and adolescents with type 1 diabetes. Diabetes Care. 2008;31:720–5.
doi: 10.2337/dc07-0824 pubmed: 18174497
Najafi MT, Khaloo P, Alemi H, Jaafarinia A, Blaha MJ, Mirbolouk M, et al. Ambulatory blood pressure monitoring and diabetes complications: Targeting morning blood pressure surge and nocturnal dipping. Medicine. 2018;97:e12185.
doi: 10.1097/MD.0000000000012185 pubmed: 30235664
Rossen NB, Knudsen ST, Fleischer J, Hvas AM, Ebbehoj E, Poulsen PL, et al. Targeting nocturnal hypertension in type 2 diabetes mellitus. Hypertension. 2014;64:1080–7.
doi: 10.1161/HYPERTENSIONAHA.114.03958 pubmed: 25259747
Kario K. Nondipping in nocturnal blood pressure in diabetes: an indicator of autonomic nervous dysfunction? Am J Hypertens. 2007;20:546–7.
doi: 10.1016/j.amjhyper.2007.03.004 pubmed: 17485019
Deyneli O, Yazici D, Toprak A, Yuksel M, Aydin H, Tezcan H, et al. Diurnal blood pressure abnormalities are related to endothelial dysfunction in patients with non-complicated type 1 diabetes. Hypertens Res. 2008;31:2065–73.
doi: 10.1291/hypres.31.2065 pubmed: 19098379
Felicio JS, de Souza AC, Kohlmann N, Kohlmann O Jr., Ribeiro AB, Zanella MT. Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes. Cardiovasc Diabetol. 2010;9:36.
doi: 10.1186/1475-2840-9-36 pubmed: 20704750
Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990;81:528–36.
doi: 10.1161/01.CIR.81.2.528 pubmed: 2137047
Nakano S, Uchida K, Kigoshi T, Azukizawa S, Iwasaki R, Kaneko M, et al. Circadian rhythm of blood pressure in normotensive NIDDM subjects. Its relationship to microvascular complications. Diabetes Care. 1991;14:707–11.
doi: 10.2337/diacare.14.8.707 pubmed: 1954805
Draman MS, Dolan E, van der Poel L, Tun TK, McDermott JH, Sreenan S, et al. The importance of night-time systolic blood pressure in diabetic patients: Dublin Outcome Study. J Hypertens. 2015;33:1373–7.
doi: 10.1097/HJH.0000000000000576 pubmed: 25882859
Tsioufis C, Andrikou I, Thomopoulos C, Syrseloudis D, Stergiou G, Stefanadis C. Increased nighttime blood pressure or nondipping profile for prediction of cardiovascular outcomes. J Hum Hypertens. 2011;25:281–93.
doi: 10.1038/jhh.2010.113 pubmed: 21124340
Tsioufis C, Andrikou I, Thomopoulos C, Petras D, Manolis A, Stefanadis C. Comparative prognostic role of nighttime blood pressure and nondipping profile on renal outcomes. Am J Nephrol. 2011;33:277–88.
doi: 10.1159/000324697 pubmed: 21372563
O’Flynn AM, Dolan E, Curtin RJ, O’Brien E, Perry IJ, Kearney PM. Night-time blood pressure and target organ damage: a comparative analysis of absolute blood pressure and dipping status. J Hypertens. 2015;33:2257–64.
doi: 10.1097/HJH.0000000000000690 pubmed: 26425836
Bouhanick B, Bongard V, Amar J, Bousquel S, Chamontin B. Prognostic value of nocturnal blood pressure and reverse-dipping status on the occurrence of cardiovascular events in hypertensive diabetic patients. Diabetes Metab. 2008;34:560–7.
doi: 10.1016/j.diabet.2008.05.005 pubmed: 18926758
Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegard K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219–29.
doi: 10.1016/S0140-6736(07)61538-4 pubmed: 17920917
Lempiäinen PA, Vasunta RL, Bloigu R, Kesäniemi YA, Ukkola OH. Non-dipping blood pressure pattern and new-onset diabetes in a 21-year follow-up. Blood Press. 2019;28:300–8.
doi: 10.1080/08037051.2019.1615369 pubmed: 31092019
Lane-Cordova AD, Kalil GZ, Wagner CJ, Sindler AL, Fiedorowicz JG, Ajibewa T, et al. Hemoglobin A1c and C-reactive protein are independently associated with blunted nocturnal blood pressure dipping in obesity-related prediabetes. Hypertens Res. 2018;41:33–8.
doi: 10.1038/hr.2017.82 pubmed: 29070829
World Health Organization & International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. World Health Organization. 2006. Available from: https://apps.who.int/iris/handle/10665/43588 .
Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation. Geneva: World Health Organization; 2011. Available from: https://www.ncbi.nlm.nih.gov/books/NBK304267/ .
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–357.2013
doi: 10.1097/01.hjh.0000431740.32696.cc pubmed: 23817082
Van De Water JM, Miller TW, Vogel RL, Mount BE, Dalton ML. Impedance cardiography: the next vital sign technology? Chest. 2003;123:2028–33.
doi: 10.1378/chest.123.6.2028
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596–e646. 2019
pmcid: 7734661 pubmed: 30879355
Aung AT, Chan SP, Kyaing TT, Lee CH. Diabetes mellitus is associated with high sleep-time systolic blood pressure and non-dipping pattern. Postgrad Med. 2020;132:346–51.
doi: 10.1080/00325481.2020.1745537 pubmed: 32208051
Nakano S, Fukuda M, Hotta F, Ito T, Ishii T, Kitazawa M, et al. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes. 1998;47:1501–6.
doi: 10.2337/diabetes.47.9.1501 pubmed: 9726241
Gavriilaki M, Anyfanti P, Nikolaidou B, Lazaridis A, Gavriilaki E, Douma S, et al. Nighttime dipping status and risk of cardiovascular events in patients with untreated hypertension: A systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2020;22:1951–9.
doi: 10.1111/jch.14039
Hermida RC, Crespo JJ, Dominguez-Sardina M, Otero A, Moya A, Rios MT, et al. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. Eur Heart J. 2020;41:4565–76.
doi: 10.1093/eurheartj/ehz754 pubmed: 31641769
Gkaliagkousi E, Nikolaidou B, Gavriilaki E, Lazaridis A, Yiannaki E, Anyfanti P, et al. Increased erythrocyte- and platelet-derived microvesicles in newly diagnosed type 2 diabetes mellitus. Diabetes Vasc Dis Res. 2019;16:458–65.
doi: 10.1177/1479164119844691

Auteurs

Barbara Nikolaidou (B)

3rd Department of Internal Medicine, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Panagiota Anyfanti (P)

3rd Department of Internal Medicine, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Eleni Gavriilaki (E)

3rd Department of Internal Medicine, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Antonios Lazaridis (A)

3rd Department of Internal Medicine, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Areti Triantafyllou (A)

3rd Department of Internal Medicine, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Hippocrates Zarifis (H)

3rd Department of Internal Medicine, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Konstantinos Mastrogiannis (K)

3rd Department of Internal Medicine, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Apostolos Tsapas (A)

Clinical Research and Evidence-Based Medicine Unit and Diabetes Centre, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Harris Manchester College, University of Oxford, Oxford, UK.

Stella Douma (S)

3rd Department of Internal Medicine, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Eugenia Gkaliagkousi (E)

3rd Department of Internal Medicine, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. eugalant@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH